benzylamine derivatives (Pfizer)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namebenzylamine derivatives (Pfizer)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNeuropeptide Y receptor type 1 antagonists

TargetsNeuropeptide Y receptor type 1

Therapy Area/IndicationsFeeding and Eating DisordersHypertensionHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsFeeding and Eating DisordersHypertensionHeart Failure

ATC CodeN/A